Andeavor
ANDV
ANDV was delisted on the 28th of September, 2018.
427 hedge funds and large institutions have $7.3B invested in Andeavor in 2013 Q4 according to their latest regulatory filings, with 98 funds opening new positions, 121 increasing their positions, 177 reducing their positions, and 52 closing their positions.
161% more call options, than puts
Call options by funds: $696M | Put options by funds: $267M
88% more first-time investments, than exits
New positions opened: 98 | Existing positions closed: 52
69% more funds holding in top 10
Funds holding in top 10: 13 → 22 (+9)
11% more funds holding
Funds holding: 383 → 427 (+44)
5% more capital invested
Capital invested by funds: $6.95B → $7.3B (+$350M)
32% less repeat investments, than reductions
Existing positions increased: 121 | Existing positions reduced: 177
Top Buyers
| 1 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$104M |
| 2 |
SCM
Steadfast Capital Management
New York
|
+$89.8M |
| 3 |
State Street
Boston,
Massachusetts
|
+$83.5M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$76.6M |
| 5 |
First Eagle Investment Management
New York
|
+$71.9M |
Top Sellers
| 1 |
SCA
SAC Capital Advisors
Stamford,
Connecticut
|
-$162M |
| 2 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
-$140M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$94.7M |
| 4 |
SFM
Systematic Financial Management
Teaneck,
New Jersey
|
-$77.4M |
| 5 |
Goldman Sachs
New York
|
-$47.4M |
ANDV Hedge Fund Activity: Q4 2013 in Review
427 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Andeavor (ANDV) for Q4 2013, worth a combined $7.3B — up 5% from $6.95B a quarter earlier.
Buyers outnumbered sellers: 98 funds opened new ANDV positions and 52 closed out — a net gain of 46 holders — while 121 added to existing stakes and 177 trimmed.
The largest buyer was PFM Health Sciences, opening a new position worth an estimated $104M. The largest seller was SAC Capital Advisors, cutting an estimated $162M.
- 427 institutional investors held Andeavor (ANDV) as of Q4 2013, up from 383 in Q3 2013.
- Funds reported $7.3B of Andeavor stock for Q4 2013, up 5% quarter-over-quarter.
- 98 funds opened new Andeavor positions in Q4 2013 and 52 closed out, a net change of +46 holders.
- The largest Andeavor buyer in Q4 2013 was PFM Health Sciences, an estimated $104M added.
- The largest Andeavor seller in Q4 2013 was SAC Capital Advisors, an estimated $162M sold.
Based on aggregated 13F filings for Q4 2013.